Application of individualized rational drug use monitoring platform in promoting rational drug use of patients with chronic diseases
返回论文页
|更新时间:2022-06-21
|
Application of individualized rational drug use monitoring platform in promoting rational drug use of patients with chronic diseases
China PharmacyVol. 33, Issue 8, (2022)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2022,
扫 描 看 全 文
LUO Zhongping, ZHAO Jianglin, LI Zhenlin, et al. Application of individualized rational drug use monitoring platform in promoting rational drug use of patients with chronic diseases. [J]. China Pharmacy 33(8).(2022)
DOI:
LUO Zhongping, ZHAO Jianglin, LI Zhenlin, et al. Application of individualized rational drug use monitoring platform in promoting rational drug use of patients with chronic diseases. [J]. China Pharmacy 33(8).(2022)DOI:
Application of individualized rational drug use monitoring platform in promoting rational drug use of patients with chronic diseases
OBJE CTIVE To provide reference for improving rational drug use in medical institutions and strengthening individualized rational drug use monitoring. METHODS The hospital information system (HIS)was used to retrieve the patient ’s medical information and the doctor ’s medical information ;on the basis of pre-examination of prescriptions ,the chronic disease medication monitoring and visiting frequency monitoring modules were added to construct individualized rational drug use monitoring platform. Taking hypoglycemic drugs as an example ,the number of patients who were prescribed the drug ≥3 times a month in Karamay Central Hospital (hereinafter referred to as “our hospital ”)was compared before and after the operation of the individualized rational drug use monitoring platform (Jan. to Apr. 2018 regarded as before operation ,Jan. to Apr. 2019 and 2021 regarded as after operation ). At the same time ,the number of risk prescriptions (repeatedly prescribing the same drug ≥3 times a day)and unreasonable prescriptions after the operation of the individualized rational drug use monitoring platform (Jan. to Apr. 2019 and Jan. to Apr. 2021)in our hospital were compared. RESULTS The proport ion of patients who were over prescribed Diformin tablets from Jan. to Apr. in 2021 was lower than the same period in 2018 significantly(16.65% vs. 27.17%,P<0.05). From Jan. to Apr. 2019,35.3% of the risk prescriptions in our hospital were unqualified prescriptions ;in the same period of 2021, the proportion of unqualified prescriptions in risk prescriptions in our hospital decreased to 12.82% ,which was statistically significant compared with 2019(P<0.05). CONCLUSIONS Based on the actual situation of patients ,our hospital establishes the individualized rational drug use monitoring platform by using HIS to meet the actual needs of clinical drug use. The use of the platform has significantly reduced the number of patients visiting doctors many times and unreasonable prescriptions ,and promotes rational drug use. At the same time ,the platform also further strengthens the prescription review system of our hospital and improves the level of pharmaceutical care.
Blood concentration monitoring of tacrolimus in patients with nephrotic syndrome and establishment of MLP prediction model
Application and evaluation of management mode for the use of antimicrobial drugs in county-level medical communities led by anti-infective clinical pharmacists
Expert consensus on comprehensive clinical evaluation of antidepressant drugs
Effect of posaconazole combined with proton pump inhibitors on blood concentrations and invasive fungal infection in patients with malignant hematological disorders
Study on the correlation between opioid-induced constipation and gene polymorphism
Related Author
YAN Xiaolu
OUYANG Hua
ZHU Longsheng
ZHENG Lingzhao
LIN Xiaoqing
LIN Xiaofeng
LI Hongyuan
DENG Xiaoqin
Related Institution
School of Advanced Technology, Xi’an Jiaotong-Liverpool University
Xiamen Pharmaceutical Association
Dept. of Pharmacy, Zhongshan Hospital Affiliated to Xiamen University
School of Pharmacy, Fujian Medical University
Dept. of Pharmacy, Zhongxian People’s Hospital of Chongqing, Chongqing Zhongxian